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The highly specific hydroxylation performed by P450 monooxygenases is a very powerful 
tool for synthetic chemists, not only at laboratory scale, but potentially also at industrial 
scale. However, despite this potential, only in a few cases has this class of enzymes been 
implemented at an industrial scale. In the case of P450s, the requirements for cofactor and 
electron transporting redox partner, coupled with conversion of hydrophobic substrates to 
hydrophobic products already set some constraints. In order to enable focused and 
directed improvement of the biocatalyst (and process), such limitations need to be 
quantified via carefully designed experiments. In this presentation, we will report the results 
of a hypothesis driven experimental approach to characterization, with the aim of 
quantifying the limitations associated with cofactor regeneration, inhibition, toxicity and 
trans-membrane transport. Selected test reactions and biocatalysts made available within 
the EC FP7 research program P4FIFTY have been used for the study, including 
CYP153A[1], CYP102A1[2] expressed in Escherichia coli and CYP106A2[3] expressed in 
Bacillus megaterium. Common limitations have been found to be the stability of the 
biocatalyst, as well as substrate inhibition and toxicity. These limitations will influence what 
we have reported as typical targets necessary to implement a commercially feasible 
process (reaction yield, biocatalyst yield, final product concentration and space-time yield). 
The analysis reveals that while further improvements are required to reach the targets, the 
remaining limitations should ultimately be possible to overcome. Such a process analysis 
tool can in principle be applied to many biocatalytic systems and it is hoped that in the 
future it will help to enable accelerated biocatalytic process development. 
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